| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $103.5M | $124.0M | $140.6M |
| YoY Revenue Growth % | -16.5% | -11.8% | — |
| Gross Profit | $25.5M | $37.6M | — |
| Gross Margin % | 24.6% | 30.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$84.1M | -$203.2M | -$199.6M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$83.4M | -$198.1M | -$203.7M |
| EBITDA (Normalized) | -$76.3M | -$196.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$30.9M | -$48.3M | -$97.6M |
| Capital Expenditures (CapEx) | $9.7M | $8.6M | — |
| Free Cash Flow (FCF) | -$40.6M | -$56.9M | -$97.6M |
| FCF Margin % | -39.2% | -45.9% | -69.4% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $39.6M | $41.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $64.5M | $118.7M | — |